1. Home
  2. VIR vs ROG Comparison

VIR vs ROG Comparison

Compare VIR & ROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.36

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Rogers Corporation

ROG

Rogers Corporation

HOLD

Current Price

$138.92

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
ROG
Founded
2016
1832
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
VIR
ROG
Price
$9.36
$138.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$19.43
$133.00
AVG Volume (30 Days)
1.6M
228.1K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
17.49
N/A
EPS
N/A
0.25
Revenue
$68,556,000.00
$879,091,000.00
Revenue This Year
$270.22
$7.64
Revenue Next Year
N/A
$6.09
P/E Ratio
N/A
$546.75
Revenue Growth
N/A
7.07
52 Week Low
$4.16
$61.17
52 Week High
$11.66
$144.46

Technical Indicators

Market Signals
Indicator
VIR
ROG
Relative Strength Index (RSI) 43.07 71.24
Support Level $8.47 $77.11
Resistance Level $10.29 N/A
Average True Range (ATR) 0.47 5.97
MACD -0.16 0.62
Stochastic Oscillator 8.48 80.19

Price Performance

Historical Comparison
VIR
ROG

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

Share on Social Networks: